telmisartan has been researched along with Diabetes Mellitus, Type 2 in 139 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 65 (46.76) | 29.6817 |
| 2010's | 65 (46.76) | 24.3611 |
| 2020's | 9 (6.47) | 2.80 |
| Authors | Studies |
|---|---|
| Chin, J; Choi, H; Choung, W; Hong, E; Jang, SM; Jang, TH; Jung, HJ; Jung, K; Kim, KH; Kim, SH; Kim, WS; Lee, BR; Lee, G; Lim, JS; Myung, J; Nam, EH; Park, M; Yang, D | 1 |
| Ammazzalorso, A; Amoia, P; Amoroso, R; Maccallini, C | 1 |
| Al-Nimer, MSM; Mohammed, MO; Wasta Esmail, VA | 1 |
| Elsinga, PH; Heeres, A; Heerspink, HJL; Mulder, DJ; Slart, RHJA; Stevens, J; van der Hoek, S; Visser, T; Willemsen, ATM | 1 |
| Curovic, VR; Hansen, TW; Heerspink, HJL; Jongs, N; Kooy, A; Kroonen, MYAM; Laverman, GD; Persson, F; Rossing, P; Sen, T; Zobel, EH | 1 |
| Eugen-Olsen, J; Hansen, TW; Heerspink, HJL; Houlind, MB; Jongs, N; Kooy, A; Kroonen, MYAM; Laverman, GD; Persson, F; Rossing, P; Rotbain Curovic, V; Tavenier, J; Zobel, EH | 1 |
| Lee, TH; Li, YR; Lin, YS; Liu, CH; Sung, PS; Wei, YC | 1 |
| Escalada, FJ; Fernández-Seara, MA; Garcia-Fernandez, N; Mora-Gutiérrez, JM; Orbe, J; Páramo, JA; Riera, M; Rodríguez, JA; Slon Roblero, MF; Soler, MJ | 1 |
| Ding, CY; Dong, ZJ; Li, Y; Meng, L; Wang, XN | 1 |
| Chen, TH; Huang, CC; Huang, WK; Lee, TH; Lee, TW; Li, YR; Liu, CH; Sung, PS; Wei, YC | 1 |
| Gaikwad, AB; Pandey, A | 1 |
| Chernatska, O; Demikhova, N | 1 |
| Arimitsu, M; Kamei, N; Koike, Y; Naruse, M; Sakamoto, R; Yambe, Y | 1 |
| Kong, D; Liu, W; Wu, W | 1 |
| Huang, Z; Nyström, T; Olverling, A; Sjöholm, Å | 1 |
| Chang, A; Kramer, H | 1 |
| Clase, CM; Dehghan, M; Dunkler, D; Gao, P; Heinze, G; Kohl, M; Mann, JF; Oberbauer, R; Teo, KK; Yusuf, S | 1 |
| Li, LY; Luo, R; Sun, LT; Tian, FS; Xiong, HL; Zhao, ZQ; Zheng, XL | 1 |
| Bandholtz, S; Goebel, M; Gust, R; Herbst, L; Kintscher, U | 1 |
| Asai, S; Kanou, N; Nakayama, T; Nishida, Y; Susa, N; Takahashi, Y | 1 |
| Sharma, K; Sweiss, N | 1 |
| Daikuhara, H; Fukunaga, K; Ohshima, T | 1 |
| Basile, JN; Gradman, AH | 1 |
| Baqar, S; Chen, AX; Ekinci, EI; Jerums, G; Lambert, E; MacIsaac, RJ; O'Callaghan, C; Somarajah, G; Thomas, G | 1 |
| D'Angelo, A; Dario Ragonesi, P; Derosa, G; Franzetti, I; Maffioli, P; Querci, F | 1 |
| Cai, G; Chen, X; Guan, X; Li, J; Li, W; Liu, M; Liu, W; Liu, Y; Lun, L; Wang, Y; Wu, H; Yao, H; Yin, S; Zhang, J; Zheng, Y; Zhou, C; Zhu, H; Zhuang, X | 1 |
| Chan, LK; Chen, L; Cheng, TW; Klein, T; Leung, PS; Zhao, S | 1 |
| Dash, R; Harnish, P; Kim, PJ; McConnell, MV; Nishimura, D; Toma, I; Yang, PC | 1 |
| Blumenthal-Katzir, T; Grigoriadis, N; Hollander, K; Lagoudakic, R; Rosenthal, T; Touloumi, O; Younis, FM | 1 |
| Chen, CH; Cheng, HM; Hoshide, S; Huang, QF; Kario, K; Park, CG; Park, S; Wang, JG | 1 |
| Gaikwad, AB; Goru, SK; Kadakol, A; Malek, V; Pandey, A; Sharma, N | 1 |
| Sharma, AM | 2 |
| Ano, N; Atsuda, K; Inoue, G; Irie, J; Kitaoka, A; Shiono, K; Toda, K; Yamada, S | 1 |
| Babazono, T; Haneda, M; Ito, S; Iwamoto, Y; Katayama, S; Kawamori, R; Makino, H; Moriya, T; Takeuchi, M | 1 |
| Arita, M; Furuta, M; Sanke, T; Shimajiri, Y; Yamana, A | 1 |
| Hosomi, N; Imanishi, M; Ito, S; Kiyomoto, H; Kobori, H; Konishi, Y; Meda, I; Mori, T; Morikawa, T; Nagai, Y; Nakagawa, T; Nishiyama, A; Okada, N; Okumura, M | 1 |
| Delles, C; Fauvel, JP; Mimran, A; Raff, U; Ruilope, LM; Schmieder, RE | 1 |
| Hamamoto, Y; Honjo, S; Ikeda, H; Koshiyama, H; Nabe, K; Wada, Y | 1 |
| Hilgers, KF; Ott, C; Raff, U; Ritt, M; Schlaich, MP; Schmieder, RE; Schneider, MP; Schuster, I | 1 |
| Asano, M; Fujinami, A; Fukui, M; Harusato, I; Hasegawa, G; Hosoda, H; Kitawaki, J; Nakamura, N; Obayashi, H; Ohta, M; Sakabe, K; Senmaru, T; Shiraishi, E; Tanaka, M; Yamasaki, M | 1 |
| Bichu, P; Khan, A; Nistala, R; Sowers, JR; Whaley-Connell, A | 1 |
| Chaisuvannarat, V; Krairittichai, U | 1 |
| Brillante, DG; Brillante, RE; Howes, LG; O'Sullivan, AJ | 1 |
| Mazerska, M; Myśliwiec, M | 1 |
| Ekinci, EI; Finch, S; Houlihan, CA; Jerums, G; Johnson, C; Macisaac, RJ; O'Callaghan, C; Panagiotopoulos, S; Thomas, D; Thomas, G | 1 |
| Elisaf, MS; Liberopoulos, EN; Rizos, CV | 1 |
| Hamada, M; Hitomi, H; Imanishi, M; Kishida, M; Kobori, H; Konishi, Y; Maeda, I; Morikawa, T; Nagai, Y; Nakagawa, T; Nakano, D; Nishiyama, A; Ohashi, N; Okumura, M | 1 |
| Mordovina, AG; Morozova, OI; Pozdniakova, NV; Sekerko, SA; Tatarchenko, IP | 1 |
| Ekinci, EI; Finch, S; Hao, H; Houlihan, C; Jerums, G; Johnson, C; MacIsaac, RJ; O'Callaghan, C; Panagiotopoulos, S; Premaratne, E; Thomas, G | 1 |
| Fujita, T; Fuke, Y; Matsumoto, K; Satomura, A; Wada, Y | 1 |
| Al-Sultan, AI; Fouad, AA; Gomaa, W; Yacoubi, MT | 1 |
| Tsutsumi, E; Yamaguchi, K | 1 |
| Cao, T; Feng, X; He, H; Liu, D; Luo, Z; Ma, L; Ma, S; Yan, Z; Yang, D; Zhao, Z; Zhu, Z | 1 |
| Mordovina, AG; Morozova, OI; Pozdniakova, NV; Tatarchenko, IP; Zaĭtseva, AV | 1 |
| Kondo, K; Nomura, Y; Oiso, Y; Ozaki, N; Sobajima, H | 1 |
| Akaza, I; Doi, M; Hirata, Y; Izumiyama, H; Tsuchiya, K; Wago, T; Yoshimoto, T | 1 |
| Fujiwara, N; Koide, H; Nakamura, T; Sato, E; Sugaya, T; Ueda, Y | 1 |
| Cheng, SS; Li, HL; Li, J; Li, X; Yuan, L | 1 |
| Awata, T; Ikebukuro, K; Inukai, K; Ito, D; Katayama, S; Kurihara, S; Ono, H; Sumita, T; Watanabe, M | 1 |
| Jugdutt, BI | 1 |
| Guo, Z; Qin, Z; Wei, P; Zheng, C | 1 |
| Makino, H; Ogawa, D | 1 |
| Dong, YF; Fukuda, M; Kataoka, K; Kim-Mitsuyama, S; Nakamura, T; Ogawa, H; Tokutomi, Y; Toyama, K; Yasuda, O | 1 |
| Chang, CH; Lai, MS; Lin, JW; Wu, LC | 1 |
| Ahn, CM; Choi, SC; Hong, SJ; Kim, JS; Lim, DS; Park, JH | 1 |
| Fujishima, H; Fujita, H; Komatsu, K; Morii, T; Narita, T; Sakamoto, T; Takahashi, T; Yamada, Y | 1 |
| Poolsup, N; Prasit, T; Suksomboon, N | 1 |
| Cao, Z; Cooper, ME | 1 |
| Goyal, BR; Goyal, RK; Mehta, AA; Parmar, K | 1 |
| Higaki, J; Horiuchi, M; Iwanami, J; Jing, F; Min, LJ; Mogi, M; Ohshima, K; Tsukuda, K | 1 |
| Takagi, H; Umemoto, T | 3 |
| Böhm, M; Fagard, R; Gao, P; Mancia, G; Pogue, J; Redon, J; Schumacher, H; Sleight, P; Teo, K; Verdecchia, P; Weber, M; Williams, B; Yusoff, K; Yusuf, S | 1 |
| Bakris, G; Kobe, M; Ley, L; Littlejohn, TW; Neutel, JM; Sharma, AM; Ting, N | 1 |
| Horiuchi, M; Iwanami, J; Jing, F; Min, LJ; Mogi, M; Ohshima, K; Shudou, M; Tsukuda, K | 1 |
| Abe, M; Fujii, Y; Ito, M; Maruyama, N; Okada, K; Soma, M; Suzuki, H; Yoshida, Y | 1 |
| Ieiri, I; Iwase, M; Kitazono, T; Matsuyama, N; Ohdo, S; Sonoki, K; Takata, Y | 1 |
| Tawfik, MK | 1 |
| Fujimoto, K; Hamamoto, Y; Honjo, S; Ikeda, H; Iwasaki, Y; Kawasaki, Y; Koshiyama, H; Mori, K; Nomura, K; Tatsuoka, H; Wada, Y | 1 |
| Arao, T; Mori, H; Nishida, K; Okada, Y; Tanaka, Y | 2 |
| Merk, D; Schubert-Zsilavecz, M | 1 |
| Guo, Z; Li, J; Xu, G; Zhang, R | 1 |
| Volpe, M | 1 |
| Dohi, Y; Kimura, G; Kojima, M; Ohashi, M | 1 |
| Chatzikyrkou, C; Menne, J | 1 |
| Chen, J; Feng, X; He, H; Li, L; Liu, D; Luo, Z; Pu, Y; Wang, P; Yu, H; Zhao, Y; Zhong, J; Zhu, Z | 1 |
| Eguchi, J; Kodera, R; Makino, H; Nakatsuka, A; Ogawa, D; Sato-Horiguchi, C; Shikata, K; Tachibana, H; Terami, N; Wada, J | 1 |
| Dhakad, PK; Joshi, M; Joshi, S; Kanawat, DS; Kurmi, MK; Mishra, A; Raikwar, SK; Sharma, AK; Sharma, P; Srinivasan, BP; Srivastava, V | 1 |
| Engeli, S; Gorzelniak, K; Janke, J; Luft, FC; Sharma, AM | 1 |
| Asmar, R; Dudley, A; Gosse, P; N'tela, G; Shepherd, GL; Topouchian, J | 1 |
| Unger, T; Zimmermann, M | 1 |
| Ciccarelli, L; Derosa, G; Fogari, R; Mugellini, A; Ragonesi, PD | 1 |
| Bertone, G; Ciccarelli, L; Cicero, AF; Derosa, G; Fogari, E; Fogari, R; Piccinni, MN | 1 |
| Doggrell, SA | 2 |
| Bain, SC; Barnett, AH; Bouter, P; Jervell, J; Karlberg, B; Madsbad, S; Mustonen, J | 1 |
| Zidek, W | 1 |
| Kurtz, TW; Pravenec, M | 1 |
| Takeuchi, M; Yamagishi, S | 1 |
| Hamamoto, Y; Honjo, S; Koshiyama, H; Nichi, Y; Wada, Y | 1 |
| Eguchi, Y; Miura, Y; Oiso, Y; Ozaki, N; Taguchi, S; Tsunekawa, S; Yamamoto, N | 1 |
| Hovind, P; Parving, HH; Rossing, P | 1 |
| Dahlöf, B; Ritz, E | 1 |
| Kintscher, U; Unger, T | 1 |
| Barnett, AH | 1 |
| Kurtz, TW | 2 |
| El-Ali, M; Ioannidis, G; Karabinos, I; Katostaras, T; Kokkinou, V; Koulouris, S; Nanas, I; Stamatelopoulos, S; Symeonides, P; Thalassinos, N; Theodoridis, T; Toutouzas, P; Triantafyllou, K; Vratsista, E | 1 |
| Luño, J | 1 |
| Tuck, ML | 1 |
| Altuntas, Y; Aydin, L; Kürklü, A; Sengul, AM | 1 |
| Baliga, V; Desai, A; Gawde, A; Hariharan, RS; Kulkarni, BN; Kulkarni, RB; Naikwadi, A | 1 |
| Pershadsingh, HA | 1 |
| Battershill, AJ; Scott, LJ | 1 |
| Böger, RH; Maas, R; Quispe-Bravo, S; Schwedhelm, E; Skamira, C | 1 |
| Barnett, A | 1 |
| Ak, ND; Fujisaka, S; Hachiya, H; Iwata, M; Kobayashi, M; Murakami, S; Sasaoka, T; Satoh, A; Senda, S; Takano, A; Takata, M; Temaru, R; Urakaze, M; Usui, I; Yamazaki, K; Yamazaki, Y | 1 |
| Remuzzi, A; Remuzzi, G | 1 |
| Hassan, H; Negro, R | 1 |
| Delles, C; Fauvel, JP; Mimran, A; Ruilope, LM; Schmieder, RE | 1 |
| Ciccarelli, L; Cicero, AF; D'Angelo, A; Derosa, G; Ferrari, I; Fogari, R; Gravina, A; Piccinni, MN; Pricolo, F; Ragonesi, PD; Salvadeo, SA | 1 |
| Derosa, G; Destro, M; Fogari, E; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Rinaldi, A; Zoppi, A | 1 |
| Itoh, Y; Mori, Y; Tajima, N | 1 |
| Cicero, AF; D'Angelo, A; Derosa, G; Fassi, R; Ferrari, I; Fogari, E; Fogari, R; Gravina, A; Ragonesi, PD; Salvadeo, SA | 1 |
| Petkow-Dimitrow, P | 1 |
| Kariv, N; Nachman, R; Rosenthal, T; Younis, F; Zangen, S | 1 |
| Davidson, J; Koval, S; Lacourcière, Y; Sharma, AM | 1 |
| Chachin, M; Hayashi, N; Hayashi, T; Horie, Y; Konomi, A; Matsumaru, T; Ohmura, T; Seidler, R; Sumida, T; Tsunenari, I | 1 |
| Fujitani, Y; Hirose, T; Ikeda, F; Kawamori, R; Mita, T; Nakayama, S; Shimizu, T; Uchino, H; Watada, H | 1 |
| Böger, RH; Galle, J; Pinnetti, S; Schwedhelm, E; Wanner, C | 1 |
| Asmar, R | 1 |
28 review(s) available for telmisartan and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Multitarget PPARγ agonists as innovative modulators of the metabolic syndrome.
Topics: Animals; Antihypertensive Agents; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Humans; Hypertension; Hypoglycemic Agents; Metabolic Syndrome; Molecular Structure; PPAR gamma; Structure-Activity Relationship | 2019 |
Adiponectin effects on the kidney.
Topics: Adiponectin; Albuminuria; Amlodipine; AMP-Activated Protein Kinases; Animals; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disease Progression; Humans; Kidney; Kidney Diseases; Mice; Obesity; Oxidative Stress; Perindopril; Renal Insufficiency, Chronic; Telmisartan | 2014 |
Target Blood Pressure in Patients with Diabetes: Asian Perspective.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Hypotension; Male; Middle Aged; Ramipril; Randomized Controlled Trials as Topic; Reference Values; Risk Factors; Stroke; Telmisartan | 2016 |
The value of current interventions for obesity.
Topics: Adipogenesis; Angiotensin II Type 1 Receptor Blockers; Bariatric Surgery; Benzimidazoles; Benzoates; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Metabolic Syndrome; Obesity; Risk Factors; Telmisartan; Weight Loss | 2008 |
Angiotensin receptor blockers for the reduction of proteinuria in diabetic patients with overt nephropathy: results from the AMADEO study.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glomerular Filtration Rate; Hemodynamics; Humans; Losartan; Mineralocorticoid Receptor Antagonists; PPAR gamma; Proteinuria; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Telmisartan; Treatment Outcome | 2009 |
Are the pleiotropic effects of telmisartan clinically relevant?
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Body Fat Distribution; Cholesterol, LDL; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Glucose; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Insulin Resistance; Kidney; PPAR gamma; Randomized Controlled Trials as Topic; Telmisartan | 2009 |
Clinical effectiveness of telmisartan alone or in combination therapy for controlling blood pressure and vascular risk in the elderly.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Comorbidity; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Polypharmacy; PPAR gamma; Prevalence; Renin-Angiotensin System; Sex Factors; Stroke; Telmisartan | 2010 |
Angiotensin receptor blockade and risk of cancer in type 2 diabetes mellitus: a nationwide case-control study.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Biphenyl Compounds; Case-Control Studies; Comorbidity; Diabetes Complications; Diabetes Mellitus, Type 2; Drug Administration Schedule; Female; Humans; Incidence; Logistic Models; Losartan; Male; Middle Aged; Neoplasms; Odds Ratio; Publication Bias; Risk Assessment; Risk Factors; Taiwan; Telmisartan; Tetrazoles | 2011 |
Systematic review of the effect of telmisartan on insulin sensitivity in hypertensive patients with insulin resistance or diabetes.
Topics: Adiponectin; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Humans; Hyperglycemia; Hyperinsulinism; Hypertension; Insulin Resistance; PPAR gamma; Randomized Controlled Trials as Topic; Telmisartan | 2012 |
Efficacy of renin-angiotensin system (RAS) blockers on cardiovascular and renal outcomes in patients with type 2 diabetes.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Hypertension; Renin-Angiotensin System; Risk Factors; Telmisartan | 2012 |
Telmisartan increases adiponectin levels: a meta-analysis and meta-regression of randomized head-to-head trials.
Topics: Adiponectin; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Coronary Disease; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Humans; Insulin Resistance; Randomized Controlled Trials as Topic; Telmisartan; Treatment Outcome | 2012 |
Telmisartan improves insulin sensitivity: a meta-analysis of randomized head-to-head trials.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Randomized Controlled Trials as Topic; Telmisartan | 2012 |
Telmisartan reduces triglyceride levels over other angiotensin II receptor blockers: a meta-analysis of randomized head-to-head trials.
Topics: Angiotensin Receptor Antagonists; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 2; Humans; Hypertension; Prospective Studies; Randomized Controlled Trials as Topic; Telmisartan; Triglycerides | 2012 |
Preventing cardiovascular events with angiotensin II receptor blockers: a closer look at telmisartan and valsartan.
Topics: Angiotensin II Type 2 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Evidence-Based Medicine; Humans; Hypertension; Telmisartan; Tetrazoles; Valine; Valsartan | 2012 |
Telmisartan - killing two birds with one stone.
Topics: 3T3-L1 Cells; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Biphenyl Compounds; Diabetes Mellitus, Type 2; Disease Models, Animal; Humans; Hypertension; Insulin Resistance; Irbesartan; Mice; PPAR gamma; Rats; Rats, Zucker; Telmisartan; Tetrazoles | 2004 |
Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin-angiotensin system.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 2; Humans; PPAR gamma; Renin-Angiotensin System; Telmisartan | 2004 |
Editorial overview: The 'sartans': is it premature to consider PPARgamma receptor agonism a bonus?
Topics: Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Hypertension; Irbesartan; Losartan; PPAR gamma; Rats; Rats, Zucker; Telmisartan; Tetrazoles | 2005 |
Vascular protection in diabetes: a pharmacological view of angiotensin II type 1 receptor blockers.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Insulin Resistance; PPAR gamma; Renin-Angiotensin System; Telmisartan | 2005 |
Preventing renal complications in diabetic patients: the Diabetics Exposed to Telmisartan And enalaprIL (DETAIL) study.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enalapril; Female; Glomerular Filtration Rate; Humans; Hypertension; Longitudinal Studies; Male; Randomized Controlled Trials as Topic; Telmisartan | 2005 |
Treating the metabolic syndrome: telmisartan as a peroxisome proliferator-activated receptor-gamma activator.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans; Hypertension; Metabolic Syndrome; PPAR gamma; Telmisartan | 2005 |
[Renin-angiotensin system in diabetic nephropathy].
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Drug Therapy, Combination; Homeostasis; Humans; Lisinopril; Losartan; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Factors; Telmisartan | 2005 |
Angiotensin-receptor blocking agents and the peroxisome proliferator-activated receptor-gamma system.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 2; Humans; Metabolic Syndrome; PPAR gamma; Telmisartan | 2005 |
Treating the metabolic syndrome using angiotensin receptor antagonists that selectively modulate peroxisome proliferator-activated receptor-gamma.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Biphenyl Compounds; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Irbesartan; Losartan; Metabolic Syndrome; PPAR gamma; Telmisartan; Tetrazoles | 2006 |
Telmisartan: a review of its use in the management of hypertension.
Topics: Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 2; Drug Combinations; Drug Therapy, Combination; Drug Tolerance; Humans; Hydrochlorothiazide; Hypertension; Hypertension, Renal; Metabolic Syndrome; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Telmisartan | 2006 |
The obese patient with diabetes mellitus: from research targets to treatment options.
Topics: Adipogenesis; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Obesity; Renin-Angiotensin System; Telmisartan; Weight Loss | 2006 |
New treatment strategies for patients with hypertension and insulin resistance.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atherosclerosis; Benzimidazoles; Benzoates; Coronary Artery Disease; Diabetes Mellitus, Type 2; Humans; Hypertension; Insulin Resistance; Metabolic Syndrome; PPAR gamma; Renin-Angiotensin System; Telmisartan | 2006 |
Potential protective effects of telmisartan on renal function deterioration.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 2; Humans; Kidney Diseases; Metabolic Syndrome; Telmisartan | 2006 |
[New therapeutic targets for ACE inhibitors and angiotensin receptor blockers].
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypertension; Losartan; Metabolic Syndrome; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Risk Reduction Behavior; Telmisartan; Treatment Outcome | 2007 |
53 trial(s) available for telmisartan and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Effects of Orlistat or Telmisartan on the Serum Free Fatty Acids in Non-alcoholic Fatty Liver Disease Patients: An Open-Labeled Randomized Controlled Study.
Topics: Diabetes Mellitus, Type 2; Double-Blind Method; Fatty Acids, Nonesterified; Humans; Non-alcoholic Fatty Liver Disease; Orlistat; Telmisartan; Triglycerides | 2022 |
Optimization of Albuminuria-Lowering Treatment in Diabetes by Crossover Rotation to Four Different Drug Classes: A Randomized Crossover Trial.
Topics: Adult; Albuminuria; Creatinine; Cross-Over Studies; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glomerular Filtration Rate; Humans; Linagliptin; Rotation; Telmisartan | 2023 |
Overall and inter-individual effect of four different drug classes on soluble urokinase plasminogen activator receptor in type 1 and type 2 diabetes.
Topics: Adult; Biomarkers; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Linagliptin; Receptors, Urokinase Plasminogen Activator; Telmisartan | 2023 |
IMPROVEMENT OF TREATMENT IN PERSONS WITH ARTERIAL HYPERTENSION AND TYPE 2 DIABETES MELLITUS.
Topics: Albuminuria; Antihypertensive Agents; Blood Pressure; Comorbidity; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Endothelin-1; Glycated Hemoglobin; Humans; Hypertension; Lisinopril; Middle Aged; Renin-Angiotensin System; Telmisartan; Treatment Outcome | 2018 |
Effects of azilsartan compared with telmisartan on insulin resistance in patients with essential hypertension and type 2 diabetes mellitus: An open-label, randomized clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Benzimidazoles; Blood Pressure; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Insulin Resistance; Male; Middle Aged; Oxadiazoles; Telmisartan | 2019 |
Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 2; Diet; Disease Progression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Feeding Behavior; Female; Follow-Up Studies; Global Health; Glomerular Filtration Rate; Humans; Incidence; Male; Middle Aged; Prospective Studies; Ramipril; Renal Insufficiency, Chronic; Risk Factors; Telmisartan; Time Factors | 2013 |
Difference in the effects of switching from candesartan to olmesartan or telmisartan to olmesartan in hypertensive patients with type 2 diabetes: the COTO study.
Topics: Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Telmisartan; Tetrazoles | 2014 |
Short-term dietary salt supplementation blunts telmisartan induced increases in plasma renin activity in hypertensive patients with type 2 diabetes mellitus.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Arterial Pressure; Benzimidazoles; Benzoates; Biomarkers; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Renin; Renin-Angiotensin System; Sodium Chloride, Dietary; Telmisartan; Time Factors; Treatment Outcome | 2015 |
Comparison of the effects of barnidipine+losartan compared with telmisartan+hydrochlorothiazide on several parameters of insulin sensitivity in patients with hypertension and type 2 diabetes mellitus.
Topics: Adipokines; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diuretics; Double-Blind Method; Drug Combinations; Female; Glucose Clamp Technique; Humans; Hydrochlorothiazide; Hypertension; Insulin Resistance; Losartan; Male; Middle Aged; Nifedipine; Telmisartan | 2015 |
Telmisartan combined with probucol effectively reduces urinary protein in patients with type 2 diabetes: A randomized double-blind placebo-controlled multicenter clinical study.
Topics: Aged; Analysis of Variance; Anticholesteremic Agents; Benzimidazoles; Benzoates; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hyperkalemia; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Probucol; Proteinuria; Telmisartan; Treatment Outcome | 2016 |
Telmisartan but not candesartan affects adiponectin expression in vivo and in vitro.
Topics: 3T3-L1 Cells; Adipocytes; Adiponectin; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Biphenyl Compounds; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; In Vitro Techniques; Insulin Resistance; Male; Mice; Middle Aged; PPAR gamma; RNA, Messenger; Telmisartan; Tetrazoles; Treatment Outcome | 2008 |
Microalbuminuria reduction with telmisartan in normotensive and hypertensive Japanese patients with type 2 diabetes: a post-hoc analysis of The Incipient to Overt: Angiotensin II Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATI
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Female; Humans; Hypertension, Renal; Japan; Male; Middle Aged; Telmisartan; Treatment Outcome | 2008 |
The angiotensin II receptor blocker telmisartan improves insulin resistance and has beneficial effects in hypertensive patients with type 2 diabetes and poor glycemic control.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Hypertension; Insulin Resistance; Male; Middle Aged; Telmisartan; Treatment Outcome | 2008 |
Olmesartan reduced microalbuminuria in Japanese subjects with type 2 diabetes.
Topics: Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Asian People; Benzimidazoles; Benzoates; Biphenyl Compounds; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hypertension; Imidazoles; Losartan; Male; Middle Aged; Telmisartan; Tetrazoles; Valine; Valsartan | 2009 |
Effects of dual blockade of renin-angiotensin system in type 2 diabetes mellitus patients with diabetic nephropathy.
Topics: Adult; Aged; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Drug Synergism; Drug Therapy, Combination; Enalapril; Female; Humans; Male; Middle Aged; Proteinuria; Renin-Angiotensin System; Telmisartan; Treatment Outcome | 2009 |
Effects of cardiovascular angiotensin II type 1 receptor blockade on nitric oxide synthase inhibition in patients with insulin resistance syndrome.
Topics: Adult; Angiotensin II; Arteries; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular System; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Hemodynamics; Humans; Insulin Resistance; Male; Metabolic Syndrome; Nitric Oxide Synthase; omega-N-Methylarginine; Photoplethysmography; Receptor, Angiotensin, Type 1; Telmisartan; Vascular Resistance | 2009 |
Telmisartan lowers albuminuria in type 2 diabetic patients treated with angiotensin enzyme inhibitors.
Topics: Aged; Albuminuria; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Pilot Projects; Telmisartan | 2009 |
Effects of salt supplementation on the albuminuric response to telmisartan with or without hydrochlorothiazide therapy in hypertensive patients with type 2 diabetes are modulated by habitual dietary salt intake.
Topics: Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Cross-Over Studies; Diabetes Mellitus, Type 2; Dietary Supplements; Female; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Sodium Chloride; Sodium, Dietary; Telmisartan | 2009 |
Salt supplementation blunts the blood pressure response to telmisartan with or without hydrochlorothiazide in hypertensive patients with type 2 diabetes.
Topics: Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Sodium Chloride, Dietary; Telmisartan | 2010 |
[The clinical and hemodynamic efficacy of telmisartan and enalapril in the treatment of arterial hypertension in patients with type 2 diabetes mellitus].
Topics: Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Carbohydrate Metabolism; Diabetes Mellitus, Type 2; Enalapril; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome; Ventricular Function, Left | 2009 |
Comparison of the effects of three angiotensin II receptor type 1 blockers on metabolic parameters in hypertensive patients with type 2 diabetes mellitus.
Topics: Adiponectin; Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Glucose; Blood Pressure; C-Reactive Protein; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Glycated Hemoglobin; Humans; Hypertension; Insulin Resistance; Lipids; Male; Middle Aged; Telmisartan; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2010 |
Improvement of endothelial function in patients with hypertension and type 2 diabetes after treatment with telmisartan.
Topics: Adiponectin; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; C-Reactive Protein; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Prospective Studies; Telmisartan; Treatment Outcome; Vasodilation | 2010 |
Renoprotective Effects of Various Angiotensin II Receptor Blockers in Patients with Early-Stage Diabetic Nephropathy.
Topics: Adult; Aged; Angiotensin Receptor Antagonists; Benzimidazoles; Benzoates; Biphenyl Compounds; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Fatty Acid-Binding Proteins; Female; Humans; Imidazoles; Losartan; Male; Middle Aged; Telmisartan; Tetrazoles; Treatment Outcome | 2010 |
Effects of telmisartan on insulin resistance in Japanese type 2 diabetic patients.
Topics: Adiponectin; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; Homeostasis; Humans; Hypertension; Insulin Resistance; Japan; Lipoproteins, LDL; Male; Metabolic Syndrome; Middle Aged; Obesity; Oxidative Stress; PPAR gamma; Telmisartan; Tetrazoles | 2010 |
[INNOVATION study].
Topics: Adult; Aged; Albuminuria; Angiotensin Receptor Antagonists; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Female; Humans; Male; Middle Aged; Telmisartan | 2010 |
Telmisartan reduces neointima volume and pulse wave velocity 8 months after zotarolimus-eluting stent implantation in hypertensive type 2 diabetic patients.
Topics: Adiponectin; Aged; Ankle Brachial Index; Anti-Inflammatory Agents; Benzimidazoles; Benzoates; C-Reactive Protein; Coronary Stenosis; Diabetes Mellitus, Type 2; Disease Progression; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Hypertension; Interleukin-6; Male; Middle Aged; Neointima; Prospective Studies; Single-Blind Method; Sirolimus; Telmisartan; Tetrazoles; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha; Ultrasonography, Interventional; Valine; Valsartan | 2011 |
Reduction of circulating superoxide dismutase activity in type 2 diabetic patients with microalbuminuria and its modulation by telmisartan therapy.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Antioxidants; Benzimidazoles; Benzoates; Cross-Over Studies; Deoxyguanosine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Japan; Losartan; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Superoxide Dismutase; Telmisartan; Tyrosine | 2011 |
Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial).
Topics: Aged; Benzimidazoles; Benzoates; Blood Pressure Determination; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Hypotension; Kaplan-Meier Estimate; Male; Middle Aged; Patient Safety; Ramipril; Reference Values; Risk Assessment; Survival Rate; Telmisartan; Treatment Outcome | 2012 |
Single-pill combination of telmisartan/amlodipine versus amlodipine monotherapy in diabetic hypertensive patients: an 8-week randomized, parallel-group, double-blind trial.
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Body Mass Index; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Severity of Illness Index; Telmisartan; Treatment Outcome | 2012 |
Additive renoprotective effects of aliskiren on angiotensin receptor blocker and calcium channel blocker treatments for type 2 diabetic patients with albuminuria.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Aged; Albuminuria; Aldosterone; Amides; Amlodipine; Angiotensin II Type 2 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Deoxyguanosine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Fatty Acid-Binding Proteins; Female; Fumarates; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Male; Middle Aged; Renin; Telmisartan; Young Adult | 2012 |
Telmisartan and N-acetylcysteine suppress group V secretory phospholipase A2 expression in TNFα-stimulated human endothelial cells and reduce associated atherogenicity.
Topics: Acetylcysteine; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Atherosclerosis; Benzimidazoles; Benzoates; Chemokine CCL2; Diabetes Mellitus, Type 2; Female; Gene Expression Regulation; Group V Phospholipases A2; Human Umbilical Vein Endothelial Cells; Humans; Hypertension; Lipoproteins, LDL; Lysophosphatidylcholines; Male; Middle Aged; RNA, Messenger; Telmisartan; Tumor Necrosis Factor-alpha | 2012 |
Telmisartan at 80 mg/day increases high-molecular-weight adiponectin levels and improves insulin resistance in diabetic patients.
Topics: Adipocytes; Adiponectin; Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Insulin; Insulin Resistance; Lipid Metabolism; Male; Middle Aged; PPAR gamma; Telmisartan; Triglycerides | 2012 |
Titration of telmisartan, but not addition of amlodipine, reduces urine albumin in diabetic patients treated with telmisartan-diuretic.
Topics: Adult; Aged; Albuminuria; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Telmisartan; Treatment Outcome | 2013 |
Antihypertensive and metabolic effects of high-dose olmesartan and telmisartan in type 2 diabetes patients with hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Benzimidazoles; Benzoates; C-Reactive Protein; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Resistance; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypoglycemic Agents; Imidazoles; Insulin Resistance; Male; Middle Aged; Telmisartan; Tetrazoles | 2013 |
Effects of telmisartan on arterial stiffness in Type 2 diabetes patients with essential hypertension.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Arteries; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Elasticity; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Pulse; Telmisartan | 2002 |
Challenges in improving prognosis and therapy: the Ongoing Telmisartan Alone and in Combination with Ramipril Global End point Trial programme.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Germany; Heart Diseases; Humans; Hypertension; Prognosis; Ramipril; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Risk Reduction Behavior; Telmisartan; Treatment Outcome | 2004 |
Effects of telmisartan compared with eprosartan on blood pressure control, glucose metabolism and lipid profile in hypertensive, type 2 diabetic patients: a randomized, double-blind, placebo-controlled 12-month study.
Topics: Acrylates; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Female; Glucose; Homeostasis; Humans; Hypertension; Imidazoles; Lipids; Male; Middle Aged; Telmisartan; Thiophenes | 2004 |
Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized, doubl
Topics: Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Nifedipine; Telmisartan; Treatment Outcome; Triglycerides | 2004 |
Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.
Topics: Adult; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Enalapril; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Prospective Studies; Telmisartan | 2004 |
Possible beneficial effect of telmisartan on glycemic control in diabetic subjects.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Glucose; Diabetes Mellitus, Type 2; Female; Humans; Hyperglycemia; Male; Telmisartan | 2005 |
Replacement of valsartan and candesartan by telmisartan in hypertensive patients with type 2 diabetes: metabolic and antiatherogenic consequences.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan; Tetrazoles; Valine; Valsartan | 2005 |
Beneficial effect of lisinopril plus telmisartan in patients with type 2 diabetes, microalbuminuria and hypertension.
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Creatinine; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Prospective Studies; Telmisartan | 2006 |
A pilot study for evaluation of the efficacy and safety of telmisartan in reducing microalbuminuria in hypertensive patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Albuminuria; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hypertension; Infant; Male; Middle Aged; Pilot Projects; Prospective Studies; Safety; Single-Blind Method; Telmisartan | 2005 |
Preventing renal complications in type 2 diabetes: results of the diabetics exposed to telmisartan and enalapril trial.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Creatinine; Diabetes Complications; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Enalapril; Glomerular Filtration Rate; Humans; Kidney Diseases; Kidney Failure, Chronic; Receptors, Angiotensin; Renin-Angiotensin System; Telmisartan | 2006 |
Telmisartan reduced blood pressure and HOMA-IR with increasing plasma leptin level in hypertensive and type 2 diabetic patients.
Topics: Adiponectin; Adult; Aged; Aged, 80 and over; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Body Mass Index; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diet, Diabetic; Female; Humans; Hypertension; Hypoglycemic Agents; Leptin; Lipids; Male; Middle Aged; Telmisartan | 2007 |
The effects of telmisartan and amlodipine on metabolic parameters and blood pressure in type 2 diabetic, hypertensive patients.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Humans; Hypertension; Insulin Resistance; Middle Aged; PPAR gamma; Telmisartan | 2006 |
Impact of telmisartan versus ramipril on renal endothelial function in patients with hypertension and type 2 diabetes.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Flow Velocity; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Female; Humans; Hypertension; Male; Middle Aged; Nitric Oxide; Ramipril; Renal Circulation; Telmisartan | 2007 |
Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-alpha.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Glucose; Blood Pressure; Body Mass Index; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Irbesartan; Leptin; Lipids; Male; Middle Aged; Rosiglitazone; Telmisartan; Tetrazoles; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2006 |
Effect of telmisartan-amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with microalbuminuria.
Topics: Adult; Aged; Albuminuria; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan | 2007 |
Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone.
Topics: Adiponectin; Administration, Oral; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Glucose; Blood Pressure; Body Mass Index; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Irbesartan; Lipids; Male; Metabolic Syndrome; Resistin; Rosiglitazone; Telmisartan; Tetrazoles; Thiazolidinediones; Treatment Outcome | 2007 |
Telmisartan/hydrochlorothiazide versus valsartan/hydrochlorothiazide in obese hypertensive patients with type 2 diabetes: the SMOOTH study.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Diabetes Mellitus, Type 2; Diastole; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Male; Middle Aged; Obesity; Placebos; Single-Blind Method; Systole; Telmisartan; Tetrazoles; Valine; Valsartan | 2007 |
Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Arginine; Benzimidazoles; Benzoates; Blood Pressure; C-Reactive Protein; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dinoprost; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Proteinuria; Renin-Angiotensin System; Telmisartan; Tetrazoles; Valine; Valsartan | 2008 |
Effect of telmisartan on arterial distensibility and central blood pressure in patients with mild to moderate hypertension and Type 2 diabetes mellitus.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Pulsatile Flow; Telmisartan; Treatment Outcome | 2001 |
58 other study(ies) available for telmisartan and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Identification of BR101549 as a lead candidate of non-TZD PPARγ agonist for the treatment of type 2 diabetes: Proof-of-concept evaluation and SAR.
Topics: 3T3-L1 Cells; Animals; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Mice; Oxadiazoles; PPAR gamma; Proof of Concept Study; Pyrimidines; Pyrimidinones; Structure-Activity Relationship | 2019 |
Studying Telmisartan Plasma Exposure, Kidney Distribution, Receptor Occupancy, and Response in Patients With Type 2 Diabetes Using [
Topics: Aged; Angiotensin Receptor Antagonists; Benzoates; Diabetes Mellitus, Type 2; Humans; Kidney; Middle Aged; Plasma; Telmisartan | 2022 |
Pioglitazone and PPAR-γ modulating treatment in hypertensive and type 2 diabetic patients after ischemic stroke: a national cohort study.
Topics: Aged; Antihypertensive Agents; Brain Ischemia; Databases, Factual; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Hypoglycemic Agents; Male; Middle Aged; Pioglitazone; Recurrence; Retrospective Studies; Risk Assessment; Risk Factors; Stroke; Taiwan; Telmisartan; Time Factors; Treatment Outcome | 2020 |
MMP-10 is Increased in Early Stage Diabetic Kidney Disease and can be Reduced by Renin-Angiotensin System Blockade.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Animals; Case-Control Studies; Cross-Sectional Studies; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Male; Matrix Metalloproteinase 10; Mice; Mice, Inbred C57BL; Middle Aged; Prognosis; Renin-Angiotensin System; Telmisartan | 2020 |
Evaluation of influence of telmisartan on the pharmacokinetics and tissue distribution of canagliflozin in rats and mice.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Canagliflozin; Diabetes Mellitus, Type 2; Mice; Rats; Sodium-Glucose Transporter 2 Inhibitors; Telmisartan; Tissue Distribution | 2021 |
Telmisartan use and risk of dementia in type 2 diabetes patients with hypertension: A population-based cohort study.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Asian People; Cohort Studies; Dementia; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Male; Taiwan; Telmisartan | 2021 |
Compound 21 and Telmisartan combination mitigates type 2 diabetic nephropathy through amelioration of caspase mediated apoptosis.
Topics: Animals; Apoptosis; Benzimidazoles; Benzoates; Caspases; Diabetes Mellitus, Type 2; Male; NF-kappa B; Rats; Rats, Wistar; Signal Transduction; Sulfonamides; Telmisartan; Thiophenes | 2017 |
Telmisartan alleviates inflammatory response and myocardial apoptosis in diabetic cardiomyopathy rats through TGF-β1/Smad signaling pathway.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Chemokine CCL2; Collagen Type I; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Interleukin-2; Lymphotoxin-alpha; Myocardium; Random Allocation; Rats; Smad Proteins; Smad3 Protein; Telmisartan; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2021 |
Acute regulation of pancreatic islet microcirculation and glycaemia by telmisartan and ramipril: discordant effects between normal and type 2 diabetic rats.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Glucose; Diabetes Mellitus, Type 2; Insulin; Islets of Langerhans; Male; Microcirculation; Pancreas; Ramipril; Rats; Rats, Wistar; Regional Blood Flow; Renin-Angiotensin System; Telmisartan | 2013 |
Moving dietary management of diabetes forward.
Topics: Benzimidazoles; Benzoates; Diabetes Mellitus, Type 2; Diet; Feeding Behavior; Female; Humans; Male; Ramipril; Renal Insufficiency, Chronic; Telmisartan | 2013 |
Angiotensin II receptor blocker telmisartan prevents new-onset diabetes in pre-diabetes OLETF rats on a high-fat diet: evidence of anti-diabetes action.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Body Weight; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Gene Expression; Hypoglycemic Agents; Inflammation; Insulin Resistance; Male; Metformin; Pioglitazone; Rats; Rats, Inbred OLETF; Telmisartan; Thiazolidinediones | 2013 |
Characterization of telmisartan-derived PPARγ agonists: importance of moiety shift from position 6 to 5 on potency, efficacy and cofactor recruitment.
Topics: 3T3-L1 Cells; Animals; Benzimidazoles; Benzoates; Benzofurans; Chlorocebus aethiops; COS Cells; Diabetes Mellitus, Type 2; Humans; Ligands; Mice; PPAR gamma; Structure-Activity Relationship; Telmisartan; Thiophenes | 2012 |
Comparative effect of angiotensin II type I receptor blockers on serum uric acid in hypertensive patients with type 2 diabetes mellitus: a retrospective observational study.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Biphenyl Compounds; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Imidazoles; Logistic Models; Losartan; Male; Middle Aged; Multivariate Analysis; Olmesartan Medoxomil; Retrospective Studies; Telmisartan; Tetrazoles; Treatment Outcome; Uric Acid; Valine; Valsartan | 2013 |
Recent clinical trials.
Topics: Antihypertensive Agents; Benzimidazoles; Benzoates; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypertension; Ramipril; Randomized Controlled Trials as Topic; Telmisartan | 2014 |
Combination of Telmisartan and Linagliptin Preserves Pancreatic Islet Cell Function and Morphology in db/db Mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blotting, Western; Cell Line, Tumor; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Drug Therapy, Combination; Female; Glucose Tolerance Test; Humans; Immunohistochemistry; Islets of Langerhans; Linagliptin; Mice; Mice, Inbred C57BL; Oxidative Stress; Pancreas; PPAR gamma; Reactive Oxygen Species; Telmisartan | 2016 |
Telmisartan in the diabetic murine model of acute myocardial infarction: dual contrast manganese-enhanced and delayed enhancement MRI evaluation of the peri-infarct region.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Benzimidazoles; Benzoates; Contrast Media; Diabetes Mellitus, Type 2; Disease Models, Animal; Endothelial Progenitor Cells; Fibrosis; Flow Cytometry; Gadolinium DTPA; Magnetic Resonance Imaging; Manganese; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Electron, Transmission; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Predictive Value of Tests; Recovery of Function; Stroke Volume; Telmisartan; Time Factors; Tissue Survival; Ventricular Function, Left | 2016 |
Telmisartan-mediated metabolic profile conferred brain protection in diabetic hypertensive rats as evidenced by magnetic resonance imaging, behavioral studies and histology.
Topics: Animals; Behavior, Animal; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Brain; Cognition; Diabetes Mellitus, Type 2; Hypertension; Magnetic Resonance Imaging; Maze Learning; Metabolome; Rats; Rats, Sprague-Dawley; Recognition, Psychology; Telmisartan | 2016 |
H2AK119 monoubiquitination regulates Angiotensin II receptor mediated macrophage infiltration and renal fibrosis in type 2 diabetic rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blotting, Western; Chemokine CCL2; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Fibrosis; Histones; Imidazoles; Kidney; Lysine; Macrophages; Male; Promoter Regions, Genetic; Pyridines; Rats, Wistar; Receptors, Angiotensin; Reverse Transcriptase Polymerase Chain Reaction; Telmisartan; Transforming Growth Factor beta1; Ubiquitination | 2016 |
Strict angiotensin blockade prevents the augmentation of intrarenal angiotensin II and podocyte abnormalities in type 2 diabetic rats with microalbuminuria.
Topics: Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Collagen; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Hypertension, Renal; Kidney Cortex; Male; Podocytes; Rats; Rats, Inbred OLETF; RNA, Messenger; Telmisartan | 2008 |
Effects of telmisartan and ramipril on adiponectin and blood pressure in patients with type 2 diabetes.
Topics: Adiponectin; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biomarkers; Blood Pressure; Cohort Studies; Confidence Intervals; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypertension, Renal; Male; Middle Aged; Ramipril; Telmisartan | 2008 |
Renal vascular endothelial function in hypertensive patients with type 2 diabetes mellitus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Male; Middle Aged; Nitric Oxide; p-Aminohippuric Acid; Ramipril; Renal Plasma Flow; Telmisartan; Vascular Resistance | 2009 |
Telmisartan, an angiotensin II type 1 receptor blocker, prevents the development of diabetes in male Spontaneously Diabetic Torii rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blotting, Western; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Gene Expression Regulation; Insulin-Secreting Cells; Male; NADPH Oxidases; Oxidative Stress; Pancreas; Rats; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Telmisartan | 2009 |
Mineralocorticoid receptor blockade enhances the antiproteinuric effect of an angiotensin II blocker through inhibiting podocyte injury in type 2 diabetic rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 2; Drug Synergism; Eplerenone; Intracellular Signaling Peptides and Proteins; Kidney Glomerulus; Male; Membrane Proteins; Mineralocorticoid Receptor Antagonists; Podocytes; Proteinuria; Rats; Rats, Inbred OLETF; Spironolactone; Telmisartan | 2010 |
[Arterial hypertension and type 2 diabetes mellitus: clinical evaluation of hemodynamic characteristics, possibility of correction].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure Monitoring, Ambulatory; Diabetes Mellitus, Type 2; Diastole; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Myocardial Contraction; Telmisartan; Treatment Outcome; Ultrasonography; Ventricular Dysfunction, Left | 2009 |
Alterations of insulin resistance and the serum adiponectin level in patients with type 2 diabetes mellitus under the usual antihypertensive dosage of telmisartan treatment.
Topics: Adiponectin; Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hypertension; Insulin Resistance; Male; Middle Aged; Prospective Studies; Telmisartan; Treatment Outcome | 2010 |
Ameliorative effects of telmisartan in diabetic rats with indomethacin-induced gastric ulceration.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Benzimidazoles; Benzoates; Blood Glucose; Caspase 3; Diabetes Mellitus, Type 2; Gastric Acid; Gastric Mucosa; Humans; Immunohistochemistry; Indomethacin; Insulin; Male; Malondialdehyde; Nitric Oxide; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Telmisartan; Tumor Necrosis Factor-alpha | 2010 |
The insulin sparing effect of telmisartan in a case of type 2 diabetes mellitus associated with schizophrenia under treatment of risperidone.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Antipsychotic Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Risperidone; Schizophrenia; Telmisartan; Tetrazoles | 2010 |
Angiotensin II receptor blocker telmisartan enhances running endurance of skeletal muscle through activation of the PPAR-δ/AMPK pathway.
Topics: Adenylate Kinase; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cells, Cultured; Diabetes Mellitus, Type 2; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Skeletal; Oxygen Consumption; Physical Endurance; PPAR delta; Running; Telmisartan | 2011 |
Effects of renin-angiotensin system blockade on the islet morphology and function in rats with long-term high-fat diet.
Topics: Animals; Apoptosis; Benzimidazoles; Benzoates; Blood Glucose; Caspase 3; Diabetes Mellitus, Type 2; Diet, High-Fat; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Interleukin-1beta; Ion Channels; Islets of Langerhans; Male; Mitochondrial Proteins; Perindopril; Rats; Rats, Wistar; Renin-Angiotensin System; Telmisartan; Uncoupling Protein 2 | 2013 |
Effect of telmisartan on the expression of cardiac adiponectin and its receptor 1 in type 2 diabetic rats.
Topics: Adiponectin; AMP-Activated Protein Kinases; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Gene Expression Regulation; Glucose Transporter Type 4; Male; Myocardium; Phosphorylation; Rats; Rats, Wistar; Receptors, Adiponectin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Streptozocin; Telmisartan | 2011 |
Telmisartan protects against diabetic vascular complications in a mouse model of obesity and type 2 diabetes, partially through peroxisome proliferator activated receptor-γ-dependent activity.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anilides; Animals; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Obesity; PPAR gamma; Telmisartan | 2011 |
Beneficial role of telmisartan on cardiovascular complications associated with STZ-induced type 2 diabetes in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dyslipidemias; Female; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Streptozocin; Telmisartan | 2011 |
Roles of interleukin 17 in angiotensin II type 1 receptor-mediated insulin resistance.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antibodies, Anti-Idiotypic; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucose; Insulin Resistance; Interleukin-17; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Receptor, Angiotensin, Type 1; Telmisartan | 2012 |
Peroxisome proliferator-activated receptor-γ activation with angiotensin II type 1 receptor blockade is pivotal for the prevention of blood-brain barrier impairment and cognitive decline in type 2 diabetic mice.
Topics: Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Anilides; Animals; Benzimidazoles; Benzoates; Blood Glucose; Blood-Brain Barrier; Blotting, Western; Cognition Disorders; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Losartan; Male; Maze Learning; Mice; Mice, Inbred C57BL; PPAR gamma; Random Allocation; Sensitivity and Specificity; Telmisartan | 2012 |
Renoprotective activity of telmisartan versus pioglitazone on ischemia/reperfusion induced renal damage in diabetic rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Glucose; Catalase; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glutathione; Hypoglycemic Agents; Inflammation Mediators; Kidney; Lipid Peroxidation; Lipid Peroxides; Oxidative Stress; Pioglitazone; Rats; Reperfusion Injury; Superoxide Dismutase; Telmisartan; Thiazolidinediones; Time Factors; Tumor Necrosis Factor-alpha | 2012 |
Relationship between telmisartan dose and glycaemic control in Japanese patients with type 2 diabetes mellitus and hypertension: a retrospective study.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Japan; Male; Middle Aged; Retrospective Studies; Telmisartan | 2012 |
[Non-agonist inhibitors of Cdk5-dependent phosphorylation of PPAR as insulin sensitizers in the future?].
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cyclin-Dependent Kinase 5; Diabetes Mellitus, Type 2; Humans; Hypertriglyceridemia; Hypoglycemic Agents; Insulin Resistance; Peroxisome Proliferator-Activated Receptors; Phosphorylation; Telmisartan | 2012 |
Effect of telmisartan on the expression of adiponectin receptors and nicotinamide adenine dinucleotide phosphate oxidase in the heart and aorta in type 2 diabetic rats.
Topics: Adiponectin; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Abdominal; Benzimidazoles; Benzoates; Chemokine CCL2; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Gene Expression Regulation; Glucose Transporter Type 4; Male; Myocardium; NADPH Oxidase 4; NADPH Oxidases; NF-kappa B; Rats; Rats, Wistar; Receptors, Adiponectin; RNA, Messenger; Telmisartan | 2012 |
Targeting albuminuria in arterial hypertension and diabetes: how is it best achieved and what is its clinical relevance?
Topics: Albuminuria; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Female; Humans; Hypertension; Male; Telmisartan | 2013 |
Telmisartan improves insulin resistance of skeletal muscle through peroxisome proliferator-activated receptor-δ activation.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Biological Transport; Cell Line; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glucose; Hypoglycemic Agents; Insulin Resistance; Ligands; Mice; Mice, Knockout; Muscle, Skeletal; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; PPAR gamma; Random Allocation; Signal Transduction; Telmisartan; Up-Regulation | 2013 |
Telmisartan attenuates diabetic nephropathy by suppressing oxidative stress in db/db mice.
Topics: Animals; Benzimidazoles; Benzoates; Cells, Cultured; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Inflammation Mediators; Male; Mice; Mice, Congenic; Mice, Inbred Strains; Oxidative Stress; Reactive Oxygen Species; Telmisartan | 2012 |
Dual therapy of vildagliptin and telmisartan on diabetic nephropathy in experimentally induced type 2 diabetes mellitus rats.
Topics: Adamantane; Albuminuria; Animals; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Blood Urea Nitrogen; Body Weight; Creatinine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diastole; Drug Therapy, Combination; Fasting; Hypoglycemic Agents; Male; Nitriles; Pyrrolidines; Rats, Wistar; Systole; Telmisartan; Vildagliptin | 2014 |
Angiotensin blockade prevents type 2 diabetes by formation of fat cells.
Topics: Adipocytes; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Cell Differentiation; Clinical Trials as Topic; Diabetes Mellitus; Diabetes Mellitus, Type 2; Disease Models, Animal; Humans; Hypoglycemic Agents; Insulin Resistance; Obesity; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Telmisartan | 2002 |
[Diabetes and Nephropathy: ACE inhibitor for type 1, AT1 blocker for type 2].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enalapril; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Long-Term Care; Renal Dialysis; Telmisartan; Treatment Outcome | 2004 |
Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Cardiovascular Diseases; Diabetes Mellitus; Diabetes Mellitus, Type 2; Humans; Hypertension; Insulin Resistance; PPAR gamma; Renin-Angiotensin System; Telmisartan; Tetrazoles; Valine; Valsartan | 2005 |
Telmisartan vs. enalapril in type 2 diabetes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enalapril; Glomerular Filtration Rate; Humans; Telmisartan; Therapeutic Equivalency | 2005 |
Introduction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Hypertension; Hypoglycemic Agents; Obesity; Telmisartan | 2005 |
Comparison of the effects of ramipril versus telmisartan in reducing serum levels of high-sensitivity C-reactive protein and oxidized low-density lipoprotein cholesterol in patients with type 2 diabetes mellitus.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; C-Reactive Protein; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Oxidation-Reduction; Ramipril; Telmisartan | 2005 |
[Telmisartan].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 2; Humans; Hypertension; Lipids; Metabolic Syndrome; PPAR gamma; Randomized Controlled Trials as Topic; Telmisartan | 2005 |
[Revised blood pressure goals and no elevated glucose readings in between].
Topics: Acarbose; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Glucose Self-Monitoring; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hyperglycemia; Hypertension; Hypoglycemic Agents; Postprandial Period; Risk Factors; Telmisartan | 2005 |
ADMA and oxidative stress may relate to the progression of renal disease: rationale and design of the VIVALDI study.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Arginine; Benzimidazoles; Benzoates; Clinical Protocols; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dinoprost; Endothelium, Vascular; Humans; Hypertension; Middle Aged; Multicenter Studies as Topic; Oxidative Stress; Randomized Controlled Trials as Topic; Renal Insufficiency; Telmisartan; Tetrazoles; Valine; Valsartan | 2005 |
[In the framework of the 72nd Annual Meeting of the DKG (German CardiologySociety) in Mannheim presented: Ontarget-the until now largest study program on cardiovascular prevention in patients with hypertension].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypertension; Metabolic Syndrome; Ramipril; Randomized Controlled Trials as Topic; Risk Factors; Telmisartan; Time Factors | 2006 |
[In the DETAIL. Kidney protection in manifestations of microalbuminuria].
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Enalapril; Glomerular Filtration Rate; Humans; Kidney; Prospective Studies; Randomized Controlled Trials as Topic; Telmisartan; Time Factors | 2006 |
[Lowering blood pressure substantially--and the diabetes risk as well?].
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitors; Circadian Rhythm; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Germany; Humans; Hypertension; Sodium Chloride Symporter Inhibitors; Telmisartan; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2006 |
Angiotensin II receptor blockers downsize adipocytes in spontaneously type 2 diabetic rats with visceral fat obesity.
Topics: Adipocytes; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Glucose; Calcium Channel Blockers; Cell Size; Diabetes Mellitus, Type 2; Disease Models, Animal; Insulin; Intra-Abdominal Fat; Male; Obesity; PPAR gamma; Random Allocation; Rats; Rats, Long-Evans; Telmisartan; Tetrazoles; Valine; Valsartan | 2007 |
Telmisartan in the treatment of Cohen-Rosenthal Diabetic Hypertensive rats: the benefit of PPAR-gamma agonism.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Disease Models, Animal; Hypertension; Hypoglycemic Agents; Insulin Resistance; Male; PPAR gamma; Rats; Rats, Inbred SHR; Telmisartan | 2007 |
Renoprotective effects of telmisartan on renal injury in obese Zucker rats.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Kidney; Male; Proteinuria; Rats; Rats, Zucker; Telmisartan; Triglycerides; Urine | 2012 |
Comparison of effects of olmesartan and telmisartan on blood pressure and metabolic parameters in Japanese early-stage type-2 diabetics with hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Imidazoles; Inflammation; Japan; Male; Metabolic Syndrome; Middle Aged; Telmisartan; Tetrazoles | 2008 |